Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> PFIZER Latest News

20 MINS AGO - Yahoo! News

A Must Read - Share

AstraZeneca plans spin-offs as cancer progress fuels bid talk

By Ben Hirschler LONDON (Reuters) - AstraZeneca announced faster-than-expected progress of its experimental cancer drugs and plans to spin off billions of dollars of non-core assets as it staked a claim for independence following reports of bid interest from Pfizer. The British firm declined to comment on Thursday about a weekend newspaper report it had spurned a 60 billion pound ...

Tags: AstraZeneca plans spin-offs as cancer progress fuels bid talk,  Pfizer Latest News

6 HOURS AGO - Yahoo! News

A Must Read - Share

AstraZeneca flags cancer advances, silent on Pfizer bid talk

AstraZeneca highlighted progress with a new generation of cancer drugs that may revive its fortunes as it posted a 17 percent fall in core earnings per share on Thursday, reflecting patent losses on profitable older medicines. Britain's second-biggest drugmaker made no reference to a reported 60 billion pound bid approach from Pfizer in its results statement. The firm's new cancer ...

Tags: AstraZeneca flags cancer advances, silent on Pfizer bid talk,  Pfizer Latest News

15 HOURS AGO - Huffington Post

A Must Read - Share

Aspirin's Effects Against Colon Cancer Depend On DNA

By Sharon Begley NEW YORK, April 23 (Reuters) - Cancer is the first disease where physicians have personalized treatment, matching a tumor's genetics to the appropriate chemotherapy, and now it may be the first in which prevention, too, can be personalized. Two decades after scientists discovered that aspirin might reduce the risk of colorectal cancer, a new study finds that ...

Tags: Aspirin's Effects Against Colon Cancer Depend On DNA,  Pfizer Latest News

APR 23, 2014 - Yahoo! News

A Must Read - Share

Novartis and GSK trade assets as pharma industry reshapes

By Caroline Copley and Paul Sandle ZURICH/LONDON (Reuters) - Novartis and GlaxoSmithKline agreed to trade more than $20 billion worth of assets on Tuesday to bolster their best businesses and exit weaker ones as the drug industry contends with healthcare spending cuts and generic competition. The deals, which include Novartis' purchase of GSK's cancer drugs and GSK's acquisition of Novartis' ...

Tags: Novartis and GSK trade assets as pharma industry reshapes,  Pfizer Latest News

APR 21, 2014 - Reuters

A Must Read - Share

Pfizer agrees to $190 million settlement over generic Neurontin

NEW YORK (Reuters) - Pfizer Inc has agreed to pay $190 million to settle a class-action lawsuit alleging the pharmaceutical company took steps to delay market entry of generic versions of its epilepsy drug Neurontin, according to court documents filed on Monday.

Tags: Pfizer agrees to $190 million settlement over generic Neurontin,  Pfizer Latest News